The product is a new vaccine against COVID-19, for use in all adults 65 and older, as well as individuals aged 12-64 years.

Adults hospitalized for RSV face higher odds of cardiac complications than those with COVID-19 or influenza, especially in ...

Respiratory Syncytial Virus (RSV) poses a significant threat to Indian infants, particularly during post-monsoon and winter, ...

From flu to gastro and RSV, these are the top five viruses spreading in winter 2025 – and what doctors recommend to help you ...

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Federal health officials issued new guidance last week on who should have the COVID-19 vaccine, and it no longer includes ...

Experts say new immunisation program working, but some babies missing outThe number of Australian babies admitted to hospital ...

Moderna has announced FDA approval for its new COVID-19 vaccine, mNexspike (mRNA-1283). This next-generation shot targets a ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

RSV causes about 100,000 deaths and more than 3.6 million hospitalisations in children under the age of 5 worldwide ...

Just three days into winter and Aussies are already losing their minds over the rapid spread of winter illnesses.